|
Volumn 85, Issue 3, 2001, Pages 375-376
|
Tissue factor as a therapeutic target
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTICOAGULANT PROTEIN;
BLOOD CLOTTING FACTOR 10;
BLOOD CLOTTING FACTOR 7;
BLOOD CLOTTING FACTOR 8A;
BLOOD CLOTTING FACTOR 9;
CHIMERIC PROTEIN;
CURCUMIN;
CYTOKINE RECEPTOR;
ENZYME PRECURSOR;
HUMAN MONOCLONAL ANTIBODY;
LIPOCORTIN 5;
PHOSPHATIDYLSERINE;
PROTEINASE INHIBITOR;
RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR;
THROMBOCYTE ANTIBODY;
THROMBOPLASTIN;
ANGIOGENESIS;
ANTIBODY AFFINITY;
ANTIINFLAMMATORY ACTIVITY;
ANTIOXIDANT ACTIVITY;
ARTERY INTIMA PROLIFERATION;
ARTERY THROMBOSIS;
ATHEROSCLEROTIC PLAQUE;
BLOOD CLOTTING;
CANCER;
CLINICAL TRIAL;
DISEASE MODEL;
DISSEMINATED INTRAVASCULAR CLOTTING;
DRUG DESIGN;
DRUG INHIBITION;
DRUG POTENCY;
DRUG PROTEIN BINDING;
DRUG TARGETING;
FIBRIN FORMATION;
GENETIC REGULATION;
GENETIC TRANSCRIPTION;
HEART INFARCTION;
HUMAN;
IN VIVO STUDY;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN EXPRESSION;
SEPSIS;
TUMOR CELL LINE;
UNSTABLE ANGINA PECTORIS;
|
EID: 0035077395
PISSN: 03406245
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0037-1615591 Document Type: Note |
Times cited : (20)
|
References (10)
|